InnovAge Holding Corp. Cash Flow Statement
INNV / Health Care|6 years of annual SEC 10-K data (FY2020-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 6 fiscal years. All figures from audited SEC 10-K filings.
InnovAge Holding Corp. generated $33M in operating cash flow and $27M in free cash flow in FY2025. Free cash flow margin was 3.1% of revenue.
Based on SEC 10-K filings.
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Net Income | -$30.3M | -$21.3M | -$40.7M | -$6.5M | -$44.0M | $26.3M |
| Depreciation & Amortization | $19.5M | $18.9M | $15.4M | $13.9M | $12.3M | $11.3M |
| Operating Cash Flow | $32.9M | -$36.9M | $20.2M | $27.3M | -$7.5M | $43.8M |
| Capital Expenditures | $6.3M | $7.9M | $23.4M | $38.2M | $17.5M | $11.8M |
| Free Cash Flow | $26.6M | -$44.8M | -$3.1M | -$10.9M | -$25.1M | $32.0M |
| Share Buybacks | - | - | - | - | $77.6M | - |
| Dividends Paid | - | - | - | - | $9.5M | - |
| FCF Margin | 3.1% | -5.9% | -0.4% | -1.6% | -3.9% | 5.6% |